Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Operating Leases (2022 - 2025)

Lucid Diagnostics (LUCD) has disclosed Operating Leases for 4 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Leases fell 59.63% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Sep 2025, down 59.63%, and an annual FY2024 reading of $1.8 million, up 37.93% over the prior year.
  • Operating Leases was $1.2 million for Q3 2025 at Lucid Diagnostics, down from $2.3 million in the prior quarter.
  • Across five years, Operating Leases topped out at $3.0 million in Q2 2024 and bottomed at $177000.0 in Q1 2024.
  • Average Operating Leases over 4 years is $1.6 million, with a median of $1.8 million recorded in 2024.
  • The sharpest move saw Operating Leases plummeted 90.57% in 2024, then skyrocketed 1295.48% in 2025.
  • Year by year, Operating Leases stood at $1.0 million in 2022, then increased by 25.84% to $1.3 million in 2023, then soared by 37.93% to $1.8 million in 2024, then tumbled by 35.72% to $1.2 million in 2025.
  • Business Quant data shows Operating Leases for LUCD at $1.2 million in Q3 2025, $2.3 million in Q2 2025, and $2.5 million in Q1 2025.